Table of Content

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of the Report
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown

Chapter 2 Summary and Highlights
Market Outlook
Market Summary

Chapter 3 Market and Technology Background
Introduction
Types of Biomarkers
Future Outlook

Chapter 4 Market Dynamics
Market Dynamics Snapshot
Market Drivers
Unmet Needs in Cancer Screening
Government Measures for Cancer Screening
Market Restraints
Risk of False Positives or False Negatives
Regulatory and Reimbursement Uncertainty

Chapter 5 Market Breakdown by Test Type
Global Multi-Cancer Diagnostic Test Market, by Test Type
Market Size and Forecast
Laboratory Developed Tests
In-Vitro Diagnostic Tests

Chapter 6 Market Breakdown by End User
Global Multi-Cancer Diagnostic Test Market, by End User
Hospitals
Diagnostic Laboratories
Research Institutions

Chapter 7 Market Breakdown by Region
Global Multi-Cancer Diagnostic Test Market, by Region
The U.S.
Europe
Emerging Markets

Chapter 8 Emerging Technologies
Introduction
Identification of Tissue of Origin
Fragmentomics and Tumor-Educated Platelets
Liquid Biopsy with Imaging Data Analysis

Chapter 9 Competitive Landscape
Porter’s Five Forces Analysis
Threat of New Entrants
Threat of Substitutes
Bargaining Power of Suppliers
Bargaining Power of Buyers
Degree of Competition
Recent Developments in the Multi-Cancer Diagnostic Market
Clinical Trial Activities

Chapter 10 Company Profiles
ANCHORDX MEDICAL CO. LTD.
BURNING ROCK BIOTECH LTD.
DELFI DIAGNOSTICS
EXACT SCIENCES CORP.
FREENOME HOLDINGS INC.
GENECAST INC.
GRAIL INC.
GUARDANT HEALTH INC.



List of Figures

 

Summary Figure A : Global Multi-Cancer Diagnostic Test Market, 2020-2028
Summary Figure B : Global Multi-Cancer Diagnostic Test Market, by Region, 2020-2028
Figure 1 : Potential Benefits of Multi-Cancer Diagnostic Tests
Figure 2 : Multi-Cancer Diagnostic Tests Market Dynamics
Figure 3 : Evidence Generation Required for Multi-Cancer Diagnostic Tests
Figure 4 : Global Multi-Cancer Diagnostic Test Market, by Test Type, 2020-2028
Figure 5 : Global Multi-Cancer Diagnostic Test Market Share, by Test Type, 2022
Figure 6 : Global Multi-Cancer Diagnostic Test Market, by End User, 2020-2028
Figure 7 : Global Multi-Cancer Diagnostic Test Market Share, by End User, 2022
Figure 8 : Global Multi-Cancer Diagnostic Test Market, by Region, 2020-2028
Figure 9 : Global Multi-Cancer Diagnostic Test Market Share, by Region, 2022
Figure 10 : Emerging Technologies in the Multi-Cancer Diagnosis Test Market

List of Tables

 

Summary Table A : Global Multi-Cancer Diagnostic Test Market, Through 2028
Summary Table B : Global Multi-Cancer Diagnostic Test Market, by Region, Through 2028
Table 1 : Cancer Screening Guidelines
Table 2 : Global Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
Table 3 : Global Multi-Cancer Diagnostic Test Market, by Laboratory Developed Tests Type, by Region, Through 2028
Table 4 : Global Multi-Cancer Diagnostic Test Market, by In-Vitro Diagnostic Test Type, by Region, Through 2028
Table 5 : Global Multi-Cancer Diagnostic Test Market, by End User, Through 2028
Table 6 : Global Multi-Cancer Diagnostic Test Market Used in Hospitals, by Region, Through 2028
Table 7 : Global Multi-Cancer Diagnostic Test Market Used in Diagnostic Laboratories, by Region, Through 2028
Table 8 : Global Multi-Cancer Diagnostic Test Market Used in Research Institutions, by Region, Through 2028
Table 9 : Global Multi-Cancer Diagnostic Test Market, by Region, Through 2028
Table 10 : The U.S. Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
Table 11 : The U.S. Multi-Cancer Diagnostic Test Market, by End User, Through 2028
Table 12 : European Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
Table 13 : European Multi-Cancer Diagnostic Test Market, by End User, Through 2028
Table 14 : Emerging Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
Table 15 : Emerging Multi-Cancer Diagnostic Test Market, by End User, Through 2028
Table 16 : Emerging Multi-Cancer Diagnostic Test Market, by Country, Through 2028
Table 17 : Porter’s Five Force Analysis of the Multi-Cancer Diagnostic Test Market
Table 18 : Recent Developments in Multi-Cancer Diagnostics, 2022 and 2023
Table 19 : Ongoing Clinical Trials for Multi-Cancer Diagnostic Tests
Table 20 : MCD Technologies of Competitor Products
Table 21 : AnchorDx Medical Co. Ltd.: Company Snapshot
Table 22 : Burning Rock Biotech Ltd.: Company Snapshot
Table 23 : Delfi Diagnostics Inc.: Company Snapshot
Table 24 : Exact Sciences Corp.: Company Snapshot
Table 25 : Freenome Holdings Inc.: Company Snapshot
Table 26 : Genecast Inc.: Company Snapshot
Table 27 : Grail Inc.: Company Snapshot
Table 28 : Guardant Health Inc.: Company Snapshot